Lanzamiento Enero 2027

Estudio2013Financiación no declaradaSolo mecanismos

Relevance of anti-inflammatory and antioxidant activities of exemestane and synergism with sulforaphane for disease prevention

Liu H, Talalay P

Proceedings of the National Academy of Sciences of the United States of America · 58 citas

Etiquetas de revisión

Financiación no declaradaSolo mecanismos

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Estudio in vitro o de mecanismos (clasificado por nuestro filtro de IA)
Estudiado en
Personas, más trabajo en animales o laboratorio
Resultado principal
Solo mecanismos

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2013-11-04 · Proc Natl Acad Sci U S A · vol. 110 · número 47 · págs. 19065–19070
Editorial
National Academy of Sciences
Citado
84 citas · más que el 93% de estudios similares · 3.4× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
39 trabajos
Acceso
Acceso abierto (copia en repositorio)
Áreas de investigación
Genomics, phytochemicals, and oxidative stress · Bioactive Compounds and Antitumor Agents · Reproductive System and Pregnancy
Palabras clave
Sulforaphane, Exemestane, Chemoprotective, Aromatase, Chemistry, Pharmacology, Biochemistry, Biology, Antioxidant, Internal medicine, Medicine, Cancer
MeSH
cell line, animals, mice, knockout, humans, mice, rats, chronic disease, reactive oxygen species, isothiocyanates, sulfoxides, androstadienes, luciferases, nad(p)h dehydrogenase (quinone), anti-inflammatory agents, antioxidants, oxidative stress, cytoprotection, drug synergism, nf-e2-related factor 2, nitric oxide synthase type ii, real-time polymerase chain reaction

2 autores

  • Hua Liu🇺🇸Johns Hopkins University; Johns Hopkins Medicine
  • Paul Talalay🇺🇸Johns Hopkins University; Johns Hopkins Medicine

Resumen

El texto original del estudio, en el idioma en que se publicó.

Exemestane (6-methyleneandrosta-1,4-diene-3,17-dione) is a synthetic steroidal inhibitor of the aromatase reaction that catalyzes the terminal and rate-limiting step of the biosynthesis of estrogens. It is active clinically in preventing, delaying progression of, and treating mammary cancers, many of which are estrogen receptor-positive. A striking feature of the structure of exemestane is an extended system of conjugated Michael reaction functions, which is also characteristic of inducers of a broad network of chemoprotective genes regulated by the Keap1 (Kelch-like ECA-associated protein)/Nrf2 (nuclear factor E2-related factor 2)/ARE (antioxidant response element) signaling system. These genes are largely involved in xenobiotic metabolism and antioxidative and anti-inflammatory protection, as well as the synthesis and reduction of glutathione. We show here that exemestane transcriptionally activates NAD(P)H:quinone oxidoreductase 1 (NQO1) and heme oxygenase 1 (HO-1), typical chemoprotective gene products, in a wide variety of mouse, rat, and human cells. It protects several cell lines against oxidative toxicity of tert-butyl hydroperoxide and 4-hydroxynonenal, against free radical damage arising from hypoxia-reoxygenation, and against UVA radiation damage. Exemestane also inhibits the inflammatory increases in inducible nitric oxide synthase (iNOS) in mouse macrophages exposed to LPS (lipopolysaccharide), thereby resembling the isothiocyanate sulforaphane derived from broccoli. Remarkably, combinations of exemestane and sulforaphane act highly synergistically, and this property is also displayed by several other phytochemicals. Thus, exemestane has a wide range of previously unrecognized protective activities, probably unrelated to aromatase inhibition. Its potential for reducing the risk, not only of breast cancer, but also of other chronic diseases that arise from inflammation, oxidative stress, and DNA-damaging electrophiles, requires exploration, particularly in view of the synergism with other phytochemicals.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.